Invasive features of superficial oesophageal squamous cell carcinoma-analysis of risk factors for lymph node metastasis.

[1]  R. Ishihara,et al.  Esophageal cancer practice guidelines 2022 edited by the Japan Esophageal Society: part 2 , 2023, Esophagus.

[2]  R. Ishihara,et al.  Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1 , 2023, Esophagus.

[3]  M. Vieth,et al.  Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2022. , 2022, Endoscopy.

[4]  T. Hirasawa,et al.  Clinical outcomes of endoscopic resection of preoperatively diagnosed non-circumferential T1a-muscularis mucosae or T1b-submucosa 1 esophageal squamous cell carcinoma , 2021, Scientific Reports.

[5]  Xiao-Wen Wang,et al.  Risk factors for lymph node metastasis in T1 esophageal squamous cell carcinoma: A systematic review and meta-analysis , 2021, World journal of gastroenterology.

[6]  T. Keck,et al.  Tumor budding as a prognostic factor in pancreatic ductal adenocarcinoma , 2019, Virchows Archiv.

[7]  Peter Schirmacher,et al.  The 2019 WHO classification of tumours of the digestive system , 2019, Histopathology.

[8]  Zhihua Liu,et al.  SERPINE2 promotes esophageal squamous cell carcinoma metastasis by activating BMP4. , 2019, Cancer letters.

[9]  大腸癌研究会.  Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma: the 3d English Edition [Secondary Publication] , 2019, Journal of the anus, rectum and colon.

[10]  T. Nemoto,et al.  Immunohistochemical analysis of tumor budding as predictor of lymph node metastasis from superficial esophageal squamous cell carcinoma , 2019, Esophagus.

[11]  Masahiro Yoshida,et al.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer , 2019, International Journal of Clinical Oncology.

[12]  T. Masaki,et al.  Risk of Lymph Node Metastasis in Patients with the Superficial Spreading Type of Esophageal Squamous Cell Carcinoma , 2019, Digestion.

[13]  D. Schaeffer,et al.  Tumor budding as a standardized parameter in gastrointestinal carcinomas: more than just the colon , 2018, Modern Pathology.

[14]  E. Vassella,et al.  MicroRNA dysregulation in the tumor microenvironment influences the phenotype of pancreatic cancer , 2017, Modern Pathology.

[15]  Phil Quirke,et al.  Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016 , 2017, Modern Pathology.

[16]  H. Yasunaga,et al.  Complications following endoscopic submucosal dissection for gastric, esophageal, and colorectal cancer: a review of studies based on nationwide large-scale databases. , 2017, Annals of translational medicine.

[17]  Japan Esophageal Society.  Japanese Classification of Esophageal Cancer, 11th Edition: part I , 2016, Esophagus.

[18]  H. Messmann,et al.  Die neue S3-Leitlinie zum Ösophaguskarzinom , 2016, Der Chirurg.

[19]  H. Stein,et al.  Predictors of Lymph Node Metastasis in Surgically Resected T1 Esophageal Cancer. , 2015, The Annals of thoracic surgery.

[20]  M. Kanda,et al.  Epithelial to mesenchymal transition correlates with tumor budding and predicts prognosis in esophageal squamous cell carcinoma , 2014, Journal of surgical oncology.

[21]  Michael S. Landau,et al.  Tumor Budding Is Associated with an Increased Risk of Lymph Node Metastasis and Poor Prognosis in Superficial Esophageal Adenocarcinoma , 2014, Modern Pathology.

[22]  D. Thickett,et al.  Epithelial–mesenchymal transition in lung development and disease: does it exist and is it important? , 2013, Thorax.

[23]  I. Zlobec,et al.  Tumour budding is a strong and independent prognostic factor in pancreatic cancer. , 2013, European journal of cancer.

[24]  T. Hibi,et al.  Solitary cell infiltration is a novel indicator of poor prognosis and epithelial-mesenchymal transition in pancreatic cancer. , 2010, Human pathology.

[25]  Y. Doki,et al.  Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy , 2009, Cancer.

[26]  Y. Kodera,et al.  Multivariate Analysis of the Pathologic Features of Esophageal Squamous Cell Cancer: Tumor Budding Is a Significant Independent Prognostic Factor , 2008, Annals of Surgical Oncology.

[27]  M. Kurosumi,et al.  Early squamous cell carcinoma of the oesophagus: the Japanese viewpoint , 2007, Histopathology.

[28]  A. Yanagisawa,et al.  Predictive factors for lymph node metastasis in esophageal squamous cell carcinomas contacting or penetrating the muscularis mucosae: the utility of droplet infiltration , 2006, Esophagus.

[29]  H. K. Kim,et al.  Tumor budding as a useful prognostic marker in esophageal squamous cell carcinoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  H. Ueno,et al.  Tumour `budding' as an index to estimate the potential of aggressiveness in rectal cancer , 2002, Histopathology.